Status update in the use of cell-penetrating peptides for the delivery of macromolecular therapeutics.

Published in: Expert opinion on biological therapy (2020)

Successful applications and clinical development with the drug conjugate approaches are discussed. On the other hand, the reasons of why the nanoparticle approaches are not as far in development are analyzed.

Keyphrases

single cell
small molecule
emergency department
stem cells
drug delivery
drug induced